Intermede Investment Partners’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
|
|||||
2024
Q3 | $74.8M | Buy |
|
|||||
2024
Q2 | $64.3M | Sell |
|
|||||
2024
Q1 | $98.2M | Buy |
|
|||||
2023
Q4 | $72.4M | Sell |
|
|||||
2023
Q3 | $80.9M | Sell |
|
|||||
2023
Q2 | $105M | Sell |
|
|||||
2023
Q1 | $117M | Buy |
|
|||||
2022
Q4 | $79.1M | Buy |
|
|||||
2022
Q3 | $65.2M | Buy |
|
|||||
2022
Q2 | $76.2M | Buy |
|
|||||
2022
Q1 | $101M | Buy |
|
|||||
2021
Q4 | $107M | Buy |
|
|||||
2021
Q3 | $93.8M | Sell |
|
|||||
2021
Q2 | $80M | Sell |
|
|||||
2021
Q1 | $64.1M | Sell |
|
|||||
2020
Q4 | $70.3M | Buy |
|
|||||
2020
Q3 | $54.8M | Sell |
|
|||||
2020
Q2 | $49.1M | Sell |
|
|||||
2020
Q1 | $37.8M | Sell |
|
|||||
2019
Q4 | $38M | Sell |
|
|||||
2019
Q3 | $41.9M | Sell |
|
|||||
2019
Q2 | $37.4M | Sell |
|
|||||
2019
Q1 | $33.4M | Buy |
|
|||||
2018
Q4 | $26.1M | Buy |
|
|||||
2018
Q3 | $31.2M | Buy |
|
|||||
2018
Q2 | $24.1M | Sell |
|
|||||
2018
Q1 | $22.2M | Buy |
|